General Discussion
Related: Editorials & Other Articles, Issue Forums, Alliance Forums, Region ForumsMembers of Congress Have $68 Million of Their Own Cash Riding on This Industry
By Delphine d'Amora |
When he came to Washington in 2013, Rep. Chris Collins (R-N.Y.) disclosed millions of dollars of investments in companies that manufacture medical devices. Now, from his seat on the House Energy and Commerce Committee, Collins has become one of the industrys most avid and influential supportersand has co-sponsored legislation that would benefit companies in which he has invested or has an ownership stake.
As reported by the health and medicine news agency STAT, Collins is hardly alone: Congressional disclosure forms reveal that about 30 percent of senators and 20 percent of representatives "held assets in biomedical and health-care companies, or in specialty funds set up to invest in those industries, during 2014." The investments totaled upward of $68 millionmore than lawmakers' combined investments in the defense and construction industriesand were concentrated on such major multinationals as Pfizer, Johnson & Johnson, and Merck. While this may appear to be a conflict of interest, there is nothing illegal in this practice.
Reporters Sheila Kaplan and Ike Swetlitz list several members of Congress on both sides of the aisle who own stock in biomedical and health care companies while working "on many issues of critical importance to the industry, including drug regulation, research funding, and taxes on medical devices." But even within this crowded landscape, Collins stands out.
The Energy and Commerce Committee's broad responsibilities include oversight of the Food and Drug Administration and policy related to public health, medical research, and drug regulation. When Collins came to the House in 2013, he reported owning a stake of between $5 million and $25 million in ZeptoMetrix, a biotechnology company he co-founded, as well as stock worth between $500,000 and $1 million in a medical device company called Chembio Diagnostics Systems. Both Chembio and ZeptoMetrix would benefit from legislation that Collins co-sponsored to repeal a tax on medical devices.
more
http://www.motherjones.com/politics/2015/12/these-congressmen-have-big-financial-stakes-industry-they-are-helping
1939
(1,683 posts)Would have more money invested in biotech and other medical stocks than in defense or construction.
1. They pay better dividends and have potential for massive growth.
2. Defense stocks are very vulnerable to a massive "outbreak of peace".
3. Construction stocks are very vulnerable to the economy.
n2doc
(47,953 posts)We had the fall of the USSR. But it was replaced by a war on an idea, which can never be eliminated, or even defined in a way that everyone agrees upon.
It is human nature to support things that directly benefit oneself. Few have the morals to expand their horizons.
BadgerKid
(4,554 posts)But are instead high-risk, high-reward speculative investments.
1939
(1,683 posts)Check out Merck, Pfizer, Glaxo-Smith-Kline, AbbVie, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Gilead Science, Novartis, Novo Nordisk, Sanofi, and Teva Pharmaceuticals. Lot better rates than you can get from a bank or T-bills and most of them buy up the speculations when they are successful.
Perseus
(4,341 posts)I believe the article has to do with "conflict of interest". People who go in politics should not be assigned to posts where they can server their self interests, their decisions will be made on profit even if it affects the people they serve.
Omaha Steve
(99,703 posts)K&R!
OS